EGFR and non-small cell lung carcinoma: Epidermal growth factor receptor (EGFR) mutations are observed in 15%–50% of non-squamous advanced NSCLC cases, particularly among women and non-smokers (Pao and Girard, 2011; Jänne and Johnson, 2006).